News NEXGEL, Inc.

Equities

NXGL

US65344E1073

Market Closed - Nasdaq Other stock markets 04:30:00 2024-04-26 pm EDT			5-day change	1st Jan Change
2.21 ^USD	-3.28%		+1.84%	+3.76%

Apr. 01	NEXGEL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 01	Transcript : NEXGEL, Inc., Q4 2023 Earnings Call, Apr 01, 2024

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024	Apr. 18	AQ
NEXGEL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Transcript : NEXGEL, Inc., Q4 2023 Earnings Call, Apr 01, 2024	Apr. 01
Earnings Flash (NXGL) NEXGEL Posts Q4 Revenue $1.1M	Apr. 01	MT
NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year	Apr. 01	AQ
NEXGEL, Inc. Provides Revenue Guidance for the First Quarter of 2023	Apr. 01	CI
NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday	Mar. 27	AQ
NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th	Mar. 21	AQ
NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th	Mar. 04	AQ
NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders	Feb. 21	AQ
NEXGEL to Present at The Microcap Conference, January 30th through February 1st	Jan. 18	AQ
NEXGEL, Inc. Announces Intention of Miranda J. Toledano to Resign as a Member of the Board of Directors, Effective as of March 31, 2024	Jan. 16	CI
Top Premarket Decliners	Jan. 16	MT
NEXGEL Subsidiary, CG Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024	Jan. 09	AQ
Nexgel Subsidiary, Cg Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024	Jan. 09	CI
NEXGEL, Inc. Announces Resignation of David Stefansky as Member of the Board of Directors	Dec. 12	CI
Nexgel Enters Deal With Stada Arzneimittel to Distribute OTC Products Across North America	Dec. 11	MT
NEXGEL, Inc. Announces Partnership with STADA Arzneimittel AG to Distribute and Commercialize Consumer Health OTC Products in North America	Dec. 11	CI
NEXGEL Announces Partnership with STADA to Distribute and Commercialize Consumer Health OTC Products in North America	Dec. 11	AQ
NEXGEL Acquires Kenkoderm Psoriasis Skincare Line	Dec. 05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News NEXGEL, Inc.

Equities

NXGL

US65344E1073

Summary

Filters